122 related articles for article (PubMed ID: 29250714)
1. Age-Related Upregulation of Carboxyl Terminal Modulator Protein Contributes to the Decreased Brain Ischemic Tolerance in Older Rats.
Li J; Shan W; Zuo Z
Mol Neurobiol; 2018 Jul; 55(7):6145-6154. PubMed ID: 29250714
[TBL] [Abstract][Full Text] [Related]
2. Elevated Expression of Carboxy-Terminal Modulator Protein (CTMP) Aggravates Brain Ischemic Injury in Diabetic db/db Mice.
Chen Y; Cai M; Deng J; Tian L; Wang S; Tong L; Dong H; Xiong L
Neurochem Res; 2016 Sep; 41(9):2179-89. PubMed ID: 27161366
[TBL] [Abstract][Full Text] [Related]
3. The endogenous inhibitor of Akt, CTMP, is critical to ischemia-induced neuronal death.
Miyawaki T; Ofengeim D; Noh KM; Latuszek-Barrantes A; Hemmings BA; Follenzi A; Zukin RS
Nat Neurosci; 2009 May; 12(5):618-26. PubMed ID: 19349976
[TBL] [Abstract][Full Text] [Related]
4. Activating Transcription Factor 3 Diminishes Ischemic Cerebral Infarct and Behavioral Deficit by Downregulating Carboxyl-Terminal Modulator Protein.
Kao MH; Huang CY; Cheung WM; Yan YT; Chen JJ; Ho YS; Hsu CY; Lin TN
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768628
[TBL] [Abstract][Full Text] [Related]
5. Small interfering RNA directed against CTMP reduces acute traumatic brain injury in a mouse model by activating Akt.
Zhao S; Fu J; Liu F; Rastogi R; Zhang J; Zhao Y
Neurol Res; 2014 May; 36(5):483-90. PubMed ID: 24670215
[TBL] [Abstract][Full Text] [Related]
6. Sevoflurane preconditioning-induced neuroprotection is associated with Akt activation via carboxy-terminal modulator protein inhibition.
Chen Y; Nie H; Tian L; Tong L; Deng J; Zhang Y; Dong H; Xiong L
Br J Anaesth; 2015 Feb; 114(2):327-35. PubMed ID: 25182017
[TBL] [Abstract][Full Text] [Related]
7. Carboxyl-Terminal Modulator Protein Positively Acts as an Oncogenic Driver in Head and Neck Squamous Cell Carcinoma via Regulating Akt phosphorylation.
Chang JW; Jung SN; Kim JH; Shim GA; Park HS; Liu L; Kim JM; Park J; Koo BS
Sci Rep; 2016 Jun; 6():28503. PubMed ID: 27328758
[TBL] [Abstract][Full Text] [Related]
8. Carboxyl-Terminal Modulator Protein Ameliorates Pathological Cardiac Hypertrophy by Suppressing the Protein Kinase B Signaling Pathway.
Liu X; Yang Q; Zhu LH; Liu J; Deng KQ; Zhu XY; Liu Y; Gong J; Zhang P; Li S; Xia H; She ZG
J Am Heart Assoc; 2018 Jun; 7(13):. PubMed ID: 29945911
[TBL] [Abstract][Full Text] [Related]
9. Carboxyl-terminal modulator protein (CTMP) deficiency mitigates denervation-induced skeletal muscle atrophy.
Wang J; Tierney L; Wilson C; Phillips V; Goldman L; Mumaw C; Muang E; Walker CL
Biochem Biophys Res Commun; 2023 Feb; 644():155-161. PubMed ID: 36652767
[TBL] [Abstract][Full Text] [Related]
10. Carboxyl-terminal modulator protein positively regulates Akt phosphorylation and acts as an oncogenic driver in breast cancer.
Liu YP; Liao WC; Ger LP; Chen JC; Hsu TI; Lee YC; Chang HT; Chen YC; Jan YH; Lee KH; Zeng YH; Hsiao M; Lu PJ
Cancer Res; 2013 Oct; 73(20):6194-205. PubMed ID: 23943800
[TBL] [Abstract][Full Text] [Related]
11. Hypermethylation and transcriptional downregulation of the carboxyl-terminal modulator protein gene in glioblastomas.
Knobbe CB; Reifenberger J; Blaschke B; Reifenberger G
J Natl Cancer Inst; 2004 Mar; 96(6):483-6. PubMed ID: 15026474
[TBL] [Abstract][Full Text] [Related]
12. The Akt signaling pathway contributes to postconditioning's protection against stroke; the protection is associated with the MAPK and PKC pathways.
Gao X; Zhang H; Takahashi T; Hsieh J; Liao J; Steinberg GK; Zhao H
J Neurochem; 2008 May; 105(3):943-55. PubMed ID: 18182053
[TBL] [Abstract][Full Text] [Related]
13. Carboxyl-terminal modulator protein (CTMP), a negative regulator of PKB/Akt and v-Akt at the plasma membrane.
Maira SM; Galetic I; Brazil DP; Kaech S; Ingley E; Thelen M; Hemmings BA
Science; 2001 Oct; 294(5541):374-80. PubMed ID: 11598301
[TBL] [Abstract][Full Text] [Related]
14. Aging causes exacerbated ischemic brain injury and failure of sevoflurane post-conditioning: role of B-cell lymphoma-2.
Dong P; Zhao J; Zhang Y; Dong J; Zhang L; Li D; Li L; Zhang X; Yang B; Lei W
Neuroscience; 2014 Sep; 275():2-11. PubMed ID: 24929064
[TBL] [Abstract][Full Text] [Related]
15. New players in high fat diet-induced obesity: LETM1 and CTMP.
Park J; Li Y; Kim SH; Yang KJ; Kong G; Shrestha R; Tran Q; Park KA; Jeon J; Hur GM; Lee CH; Kim DH; Park J
Metabolism; 2014 Mar; 63(3):318-27. PubMed ID: 24333006
[TBL] [Abstract][Full Text] [Related]
16. Novel link of anti-apoptotic ATF3 with pro-apoptotic CTMP in the ischemic brain.
Huang CY; Chen JJ; Wu JS; Tsai HD; Lin H; Yan YT; Hsu CY; Ho YS; Lin TN
Mol Neurobiol; 2015 Apr; 51(2):543-57. PubMed ID: 24771044
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotection induced by sevoflurane-delayed post-conditioning is attributable to increased phosphorylation of mitochondrial GSK-3β through the PI3K/Akt survival pathway.
Ye Z; Xia P; Cheng ZG; Guo Q
J Neurol Sci; 2015 Jan; 348(1-2):216-25. PubMed ID: 25555490
[TBL] [Abstract][Full Text] [Related]
18. Lentivirus-mediated carboxyl-terminal modulator protein gene transfection via aerosol in lungs of K-ras null mice.
Hwang SK; Kwon JT; Park SJ; Chang SH; Lee ES; Chung YS; Beck GR; Lee KH; Piao L; Park J; Cho MH
Gene Ther; 2007 Dec; 14(24):1721-30. PubMed ID: 17960162
[TBL] [Abstract][Full Text] [Related]
19. Astrocytic Expression of CTMP Following an Excitotoxic Lesion in the Mouse Hippocampus.
Shin N; Yi MH; Kim S; Baek H; Triantafillu UL; Park J; Kim DW
Exp Neurobiol; 2017 Feb; 26(1):25-32. PubMed ID: 28243164
[TBL] [Abstract][Full Text] [Related]
20. Carboxy-terminal modulator protein attenuated extracellular matrix deposit by inhibiting phospho-Akt, TGF-β1 and α-SMA in kidneys of diabetic mice.
Chen N; Hao J; Li L; Li F; Liu S; Duan H
Biochem Biophys Res Commun; 2016 Jun; 474(4):753-760. PubMed ID: 27166156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
